Our results have revealed that two genes involved in cholesterol metabolism [44], LDLR and PCSK9, are associated with the presence of aPLA and with the susceptibility of developing thrombosis among individuals with high aPLA titers. The gene discussed is PCSK9; the disease is Venous thrombosis.